Dr. Indra Bole, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 315
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
OH license 35.143026 -
Cardiovascular Disease Physician
OH license 35.143026
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Ohio State University State Health System Columbus, OH
- Memorial Hospital Marysville, OH
- Mercer County Joint Township Community Hospital Coldwater, OH
- Mary Rutan Hospital Bellefontaine, OH
Medical groups
- Osu Internal Medicine LLC (1,161 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 315
- Services billed
- 758
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 201 | 52 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 139 | 139 |
| Established patient office or other outpatient visit, 30-39 minutes | 127 | 99 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 78 | 75 |
| New patient office or other outpatient visit, 45-59 minutes | 61 | 61 |
| Critical care, first 30-74 minutes | 38 | 12 |
| Hospital discharge day management, more than 30 minutes | 35 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 22 | 11 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 22 | 22 |
| Ultrasound of heart, follow-up | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Dublin, OH | 190 |
| Metoprolol Succinate Other prescribers in Dublin, OH | 166 |
| Rosuvastatin Calcium Other prescribers in Dublin, OH | 132 |
| Jardiance (empagliflozin) Other prescribers in Dublin, OH | 103 |
| Furosemide Other prescribers in Dublin, OH | 98 |
| Entresto (sacubitril/valsartan) Other prescribers in Dublin, OH | 98 |
| Atorvastatin Calcium Other prescribers in Dublin, OH | 77 |
| Losartan Potassium Other prescribers in Dublin, OH | 71 |
| Amlodipine Besylate Other prescribers in Dublin, OH | 70 |
| Torsemide Other prescribers in Dublin, OH | 62 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $44,462 in research payments for these studies, mostly to the institutions running them.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.